Metformin suppresses lung adenocarcinoma by downregulating AFAP1-AS1 and regulating the AFAP1-AS1/miR-3163/SPP1/PI3K/Akt/mTOR axis. This evidence concerns the gene AFAP1 and lung adenocarcinoma.